NCT05985486

Brief Summary

The goal of this study is to determine if weight loss or changes in dietary intake can help prevent of delay adults with Down syndrome from developing Alzheimer's Disease Adults with Down syndrome without dementia will be randomized to either a weight loss group or a general health education control group. The weight loss group will be asked to follow a reduced energy diet, attend monthly education sessions delivered remotely and self-monitor diet and body weight using commercially available web-based applications. The control group will be asked to attend remotely delivered monthly education sessions on general health education topics. All participants will come to the University of Kansas Medical Center, 3 times across 12 months for a blood draw, cognitive testing, a MRI, assessment of height and weight, and assessment of diet intake.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable

Timeline
16mo left

Started Oct 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Oct 2024Sep 2027

First Submitted

Initial submission to the registry

August 2, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 14, 2023

Completed
1.2 years until next milestone

Study Start

First participant enrolled

October 22, 2024

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2027

Last Updated

March 11, 2026

Status Verified

March 1, 2026

Enrollment Period

2.9 years

First QC Date

August 2, 2023

Last Update Submit

March 9, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Plasma Amyloid beta 42:40 ratio

    Examines the amount of amyloid beta in a person's brain, measured by a blood draw.

    Baseline, 6, 12 months

  • Neurofilament light

    Examines the amount of Neurofilament light in a person's brain, measured by a blood draw.

    Baseline, 6, 12 months

  • Weight

    Examines how much a person weights, measured by standing on a scale.

    Baseline, 6, 12 months

Secondary Outcomes (9)

  • Dietary Intake

    Baseline, 6, 12 months

  • Skin carotenoid content

    Baseline, 6, 12 months

  • Plasma Phosphorylated Tau

    Baseline, 6, 12 months

  • Glial Fibrillary Acidic Protein

    Baseline, 6, 12 months

  • Brian Volume

    Baseline, 12 months

  • +4 more secondary outcomes

Other Outcomes (6)

  • Height

    Baseline, 6, 12 months

  • Waist circumference

    Baseline, 6, 12 months

  • Attendance at education sessions

    Across 12 months

  • +3 more other outcomes

Study Arms (2)

Weight Loss

EXPERIMENTAL

* Follow a reduced calorie diet daily for 12 months. * Attend monthly behavioral counseling/education

Behavioral: DietBehavioral: Health Education

General Health Education Control

ACTIVE COMPARATOR

\- Attend monthly health education sessions about general health.

Behavioral: Health Education

Interventions

DietBEHAVIORAL

A reduced calorie diet which uses frozen meals purchased at the store and focuses on increasing fruits and vegetables associated with brain health.

Weight Loss

Monthly health education sessions delivered remotely.

General Health Education ControlWeight Loss

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosis of Down syndrome
  • BMI of 25 to 50 kg/m2
  • Ability to communicate through spoken language.
  • Ability to come to the University of Kansas Medical Center 3 times across 1 year for outcomes testing
  • Living at home with a parent/guardian, or in a supported living environment with a caregiver who assists with food shopping, meal planning, and meal preparation and agrees to serve as a study partner including providing transportation to our facilities for study assessments.

You may not qualify if:

  • Diagnosis of dementia
  • Insulin dependent diabetes
  • Participation in a weight management program involving diet or physical activity in the past 6 mos.
  • Dairy allergy
  • Serious medical risk (e.g., cancer, recent heart attack, stroke, pregnancy, angioplasty)
  • Unwilling to be randomized
  • Contraindications for MRI, including metal implants or devices incompatible with MRI such as pacemakers, claustrophobia, and inability to lay in a supine position
  • Use of GLP-1 medications
  • Use of anti-amyloid medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

RECRUITING

MeSH Terms

Conditions

Down SyndromeAlzheimer DiseaseObesity

Interventions

Diet

Condition Hierarchy (Ancestors)

Intellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesChromosome DisordersGenetic Diseases, InbornDementiaBrain DiseasesCentral Nervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Central Study Contacts

Lauren Ptomey, PhD

CONTACT

Jessica Danon

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 2, 2023

First Posted

August 14, 2023

Study Start

October 22, 2024

Primary Completion (Estimated)

September 30, 2027

Study Completion (Estimated)

September 30, 2027

Last Updated

March 11, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations